首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 218 毫秒
1.
分别用CIDR(孕酮阴道栓)+PMSG(处理1)和CIDR+PMSG+LH(处理2)两种处理方法对山羊进行同期发情处理。结果发现,两种处理均以撤栓后第1d发情率最高。撒栓后0-24h和24h-48h的发情率,处理1和处理2(61.4%,13.6%和48%,20%)之间差异不显著;撤栓后48h-72h的发情率,处理1(4.59,6)显著低于处理2(24%)(P〈0.05);撤栓后0~72h发情率,两种处理(79.5%,92%)无显著差异(P〉0.05)。从手术时对卵巢的观察可以看出,有大卵泡或排卵的发情羊,处理1为91.2%,处理2为100%,二者无显著差异;排卵的发情羊,处理1为(58.8%)显著低于处理2为(91.2%)(P〈0.05)。  相似文献   

2.
分别用CIDR(孕酮阴道栓)+PMSG(处理1)和CIDR+PMSG+LH(处理2)两种处理方法对山羊进行同期发情处理。结果发现,两种处理均以撤栓后第1d发情率最高。撒栓后0-24h和24h-48h的发情率,处理1和处理2(61.4%,13.6%和48%,20%)之间差异不显著;撤栓后48h-72h的发情率,处理1(4.59,6)显著低于处理2(24%)(P〈0.05);撤栓后0~72h发情率,两种处理(79.5%,92%)无显著差异(P〉0.05)。从手术时对卵巢的观察可以看出,有大卵泡或排卵的发情羊,处理1为91.2%,处理2为100%,二者无显著差异;排卵的发情羊,处理1为(58.8%)显著低于处理2为(91.2%)(P〈0.05)。  相似文献   

3.
选择产羔后 30~ 6 0天、6 1~ 90天和 91天以上的徐淮白山羊乏情母羊 772头 ,分别用含孕酮水平不一致的三种“诱情素”处理 12天 ,或用 0 0 5~ 0 75mg的氯前列烯醇处理 ,并用试验同期未作任何处理的母羊作对照。结果发现 ,用“诱情素Ⅰ”、“诱情素Ⅱ”和“诱情素Ⅲ”处理的母羊 ,在撤栓后 3~ 5天内分别有 6 4 3%、76 6 %和 80 5 %的母羊发情 ,而用氯前列烯醇处理的母羊以及对照组母羊 ,分别只有 33 1%和 7 1%在同期内表现发情 ,发情配种后 ,各组母羊的不返情率相近。分析影响诱导发情效果的因素 ,发现孕酮用量与诱导发情率呈正相关关系 ,此外 ,处理月份和处理时母羊距产羔间隔时间均对诱导发情效果有影响。  相似文献   

4.
重构胚移植用受体山羊同期发情处理效果比较   总被引:2,自引:0,他引:2  
本实验分别用两种CIDR PMSG(处理1)和CIDR PMSG LH(处理2)方法对山羊进行同期发情处理。结果发现,两种处理均以撤栓后第1d发情率最高。撤栓后0~24h和24~48h发情率,两种处理(61.4%,13.6%;48%,20%)之间差异不显著;撤栓后48~72h发情率,处理1(4.5%)显著低于处理2(24%)(P<0.05);撤栓后0~72h发情率,两种处理(79.5%,92%)无差异(P>0.05)。手术后卵巢观察可以看出,有大卵泡或排卵的发情羊,处理1为91.2%,处理2为100%,二者无显著差异;排卵的发情羊,处理1(58.8%)显著低于处理2(91.2%)(P<0.05)。  相似文献   

5.
为了比较十八甲基炔诺酮(NG)和左旋十八甲基炔诺酮(LNG)对奶山羊同期发情效果,为奶山羊养殖场选择合适的孕激素阴道海绵栓进行奶山羊的同期发情处理提供基础研究资料。将108只健康奶山羊随机分为三组,每组3个重复,每重复12只羊;3个试验组羊分别采用氯前列烯醇(PG,0.1 mg/只)+不同类型和剂量十八甲基炔诺酮阴道海绵栓+50单位促卵泡素(FSH)进行同期发情处理,其中试验1组采用NG 60 mg/枚的阴道海绵栓,试验2组采用LNG30 mg/枚的阴道海绵栓,试验3组采用LNG 40 mg/枚的阴道海绵栓。结果表明,三组羊96 h发情同期率分别为86.11%、94.44%和88.89%,各组间差异不显著(P0.05);72 h的发情同期率分别为80.53%、94.44%和88.89%,第2组显著高于第1组(P0.05),但与第3组差异不显著(P0.05);从处理结束到发情开始的平均间隔时间分别为45.29 h±18.99、48.35 h±13.02和42.38 h±12.19;发情持续时间分别为30.19 h±11.95、30.71 h±8.11和29.63 h±8.41,均无显著差异。综合分析表明,LNG对奶山羊发情同期效果优于NG,且30 mg LNG的效果比40 mg LNG效果好,建议在制作羊用阴道海绵栓时选择LNG,并采用30 mg LNG/枚的剂量。  相似文献   

6.
将99只辽宁绒山羊分2批、4组,于春、秋两季进行同期发情试验。在秋季采用A组CIDR+PMSG+PG(埋栓14 d)和B组CIDR+PG(埋栓14 d),春季采用C组CIDR+PMSG+PG(埋栓19 d)和D组CIDR+PMSG(埋栓19 d)。结果表明:①秋季撤栓前加注250 u PMSG,同期发情率极明显高于单注PG组(P<0.01),且发情集中在撤栓后的0~24 h。②春季撤栓时加注PG,可显著提高发情率(P<0.01)。③用同一组激素处理,秋季与春季的同期发情率差异显著(P<0.05)。两季节假发情率春季高于秋季,差异极显著(P<0.01)。  相似文献   

7.
对 2 2 4只云岭黑山羊及其杂交羊在夏季用CIDR孕酮栓 PMSG法进行同期发情处理 ,结果表明 :①总体发情率为64 73 % ,移植率为 47 3 2 % ,其中发情羊在撤栓后 48小时内 10 0 %发情 ,同期化程度高 ;②楚雄羊 (n =44只 )、师宗羊 (n =96只 )、文山羊 (n =71只 )和杂交羊 (n =9只 ) ,发情率分别为 :5 2 2 7%、65 63 %、66 2 0 %和 10 0 0 0 % ,以杂交羊的同期发情率和移植率高于楚雄山羊 (P <0 0 1)、师宗山羊和文山山羊 (P <0 0 5 ) ,但三个地方的云岭黑山羊的发情率和移植率均无显著差异 (P >0 0 5 ) ;③ 1~ 2 5岁受体羊的发情率比 3~ 5岁羊高 17 74个百分点 (P <0 0 5 ) ,移植率高 11 0 6个百分点(P >0 0 5 ) ;④ 2 0~ 2 9kg羊的发情率分别比 3 0~ 3 9kg和 40~ 5 1kg的羊群高 19 2 3个百分点 (P <0 0 5 )和 2 6 0 1个百分点(P <0 0 1) ;移植率分别高 13 0 7和 14 83个百分点 (P >0 0 5 ) ;⑤青年羊的掉栓率显著低于经产羊 (P <0 0 5 ) ,而掉栓羊群和持栓羊群的发情率和移植率分别比较 ,差异不显著 (P >0 0 5 ) ;⑥处理羊在第 16天撤栓和第 17天撤栓的同期发情率差异不显著 (P >0 0 5 )。  相似文献   

8.
2008年5-7月在青海省天峻县生格乡应用孕马血清(PMSG),结合阴道海绵栓同期发情技术处理经产高原型藏系母羊385只、撤栓后0~72h发情313只,同期发情率81.30%;产羔288只,产羔率91.9%,成活259只,成活率89.0%。  相似文献   

9.
采用4种同期发情方法处理哈萨克羊,比较发情和产羔性能,筛选出便捷有效的同期发情方法,提高羊繁殖率.568头成年哈萨克羊分为4组,第Ⅰ、Ⅱ、Ⅲ组阴道埋置海绵栓13 d,撤栓后分别肌肉注射100μgPG+350 IUeCG、350 IU eCG、100 μg PG,Ⅳ组阴道埋置CIDR栓13 d,撤栓后肌肉注射100μgP...  相似文献   

10.
乏情季节诱导山羊同期发情的研究   总被引:12,自引:2,他引:10  
通过对云阳县栖霞乡放牧 +舍饲条件下的经产母羊 3组 (A组 40只、B组 3 1只、C组 18只 )共 89只分别用孕激素阴道栓同期发情处理 10天 ,其中A组取栓后直接观察发情情况、B和C组取栓后分别注射PGF2α 0 0 5mg/只和 0 1mg/只。结果表明 :A组 2~ 4天内同期发情率为 42 5 0 % ;B组同期发情率为 67 74% ,48小时有羊只发情高峰 ;C组同期发情率为83 3 3 %。取栓至开始发情时间A组明显长于B组和C组 (P <0 0 5 ) ;平均发情持续时间短于B、C组 (P <0 0 1,P <0 0 5 ) ,B、C组之间差异不显著 (P >0 0 5 )。  相似文献   

11.
This study evaluated the effect of the protected fatty acid inclusion during estrus synchronization on reproductive parameters. Goats (n = 32) received progestagen sponges for 6 days and 200 IU equine chorionic gonadotropin and 30 µg d‐cloprostenol were given on Day 5. No difference was found among control (C), 1% protected fatty acid inclusion (C + 1%) or 4% protected fatty acid inclusion (C + 4%) groups, respectively, in estrus (100.0, 100.0 or 90.9%), estrus duration (31.6 ± 12.3; 43.2 ± 12.9 or 40.8 ± 14.1 h), animals ovulating (100.0, 90.0 or 100.0%) or ovulation rate (1.3 ± 0.5; 1.1 ± 0.3 or 1.2 ± 0.4). The interval from sponge removal to ovulation and from estrus to ovulation, respectively, were shorter for C + 4% (45.2 ± 8.0 h; 18.3 ± 11.0 h) compared with C (56.3 ± 12.6 h; 30.6 ± 10.5 h) or C + 1% (57.7 ± 8.7 h; 30.3 ± 11.1 h). The average ovulatory follicle diameter was smaller for C + 4% (6.2 ± 0.7 mm) than C (7.5 ± 0.8 mm), but similar to C + 1% (7.0 ± 1.5 mm). Insulin, insulin‐like growth factor 1, glucose and progesterone concentrations were similar among groups. The inclusion of protected fatty acid during synchronization treatment promoted no benefits on ovulation rate, but 4% anticipated the ovulation time.  相似文献   

12.
We compared synchronization and pregnancy rates, and the increase in blood progesterone concentrations during luteal development, between (1) Ovsynch plus an intravaginal controlled internal drug release (CIDR) device protocol followed by timed embryo transfer (timed ET), and (2) a conventional estrus synchronization method using PGF(2 alpha) and ET in suckled postpartum Japanese Black beef cows. Cows in the PGF group (n=18) received a PGF(2 alpha) analogue when a CL was first palpated per rectum at 10-d intervals after 1 to 2 month postpartum. Cows (n=11), which showed estrus (Day 0) within 5 d of the PGF(2 alpha), and had a CL on Day 7, received ET. Cows in the Ovsynch+CIDR group (n=19) underwent the Ovsynch protocol plus a CIDR for 7 d (GnRH analogue and CIDR on Day-9, PGF(2alpha) analogue with CIDR removal on Day-2, and GnRH analogue on Day 0), with ET on Day 7. The ovulation synchronization (100%) and embryo transfer (100%) rates in the Ovsynch+CIDR group were greater (P<0.01) than the estrus synchronization (66.7%) and the embryo transfer (61.1%) rates in the PGF group. The postpartum interval at ET in the Ovsynch+CIDR group (62.5 +/- 2.5 d) was shorter (P<0.01) than in the PGF group (74.9 +/- 3.9 d). The pregnancy rate in the Ovsynch+CIDR group (57.9%) did not differ significantly from that in the PGF group (50.0%). Plasma progesterone concentrations were not significantly different in the two groups on Days 0, 1, 2, 5, 7, 14 and 21. In summary, higher synchronization and transfer rates, and shorter postpartum interval to ET, can be achieved with timed ET following the Ovsynch plus CIDR protocol than after estrus with the single PGF(2 alpha) treatment followed by ET in suckled postpartum recipient beef cows. Pregnancy rates were similar. Also, the increase in blood progesterone concentrations during luteal development following ovulation synchronized by the Ovsynch plus CIDR protocol was similar to that after estrus induced by the PGF(2 alpha) treatment.  相似文献   

13.
The effect of pretreatment with flurogestone acetate (FA) on the lifespan of corpora lutea induced with pregnant mare serum gonadotropin (PMS) was examined in cycling and anestrous ewes. Cycling ewes received one of three treatments: 750 IU PMS 2 d before expected estrus (P), FA-impregnated vaginal sponges for 16 d (F), and FA sponges for 16 d and 750 IU PMS 2 d before sponge removal (FP). A fourth group served as controls (C). When compared with d 12 means within treatment, plasma progesterone means were lower (P less than .05) on d 16 in control ewes, on d 15 in P and F ewes, and on d 14 in FP ewes. Only 44% of ewes receiving FA treatment alone exhibited estrus (P less than .05) compared with 100% of untreated ewes. The FP treatment increased ovulation rate compared with controls (P less than .01). The decrease in luteal lifespan observed in cycling ewes suggests a possibility of asynchrony between the uterus and embryo, which could result in failure of an embryo to prevent luteal regression, thus resulting in reduced fertility. None of the seasonally anestrous ewes that received PMS alone and only 55% of those treated with FA sponges for 8 d before PMS injection exhibited estrus. Ewes pretreated with FA exhibited higher plasma progesterone concentrations on d 10 through 16 after PMS injection. There were no differences in luteal lifespan as measured by peripheral plasma progesterone patterns. Although FA treatment did not alter luteal lifespan in anestrous ewes, the increased plasma progesterone concentrations observed with FA treatment suggest that progestogen pretreatment may be essential for optimal luteal function.  相似文献   

14.
Experiments were conducted to compare the efficacy of synthetic progestogens administered by subcutaneous ear implant or intravaginal sponge to induce a synchronized estrus in adult ewes and ewe lambs and to evaluate reproductive performance (fertility and litter size) to breeding at the synchronized estrus. Experimental animals were representative of three strains maintained in total confinement and exposed to a synthetic light regimen which alternated at intervals of 4 mo from 18 h day length to 10 h day length/24 h. Treatments were applied at different times of the year at the end of a low light cycle. Implants contained Norgestomet (3 mg) impregnated in a polymethacrylate polymer (Implant H) or impregnated in a silastic polymer containing 1.05 (Implant S1), 1.78 (Implant S2) or 2.60 mg (Implant S3) Norgestomet, respectively. Intravaginal sponges contained 40 mg Fluorogestone Acetate. Implants or sponges were left in situ for 12 d and 500 IU pregnant mares' serum gonadotropin was injected im at the time of removal. Following treatment with Implant H, 96% of ewes were judged to be in estrus at 48 h after implant removal. Fertility of adult ewes and ewe lambs (6 to 7 mo of age at time of breeding) at the synchronized estrus were similar after implant H or sponge treatment, but litter size was higher (P less than .05) for adult ewes treated with sponges. The percentages of adult ewes marked by rams within 60 h after removal of silastic implants or intravaginal sponges were similar. There was a tendency for ewe lambs to be marked later than adult ewes and for adult ewes treated with Implant S1 and Implant S2 to be marked earlier than ewes treated with Implant S3 or sponges. Higher percentages (P less than .05) of adult ewes and ewe lambs lambed to breeding at the synchronized estrus after treatment with Implant S2 or Implant S3, respectively, than after treatment with Implants S2 or sponges.  相似文献   

15.
Eight seasonally anestrous mares were administered intravaginal polyurethane sponges on December 15 and then weekly thereafter until February 1. Control mares received no sponges or genital contact. Sponge insertion caused an immediate surge in follicle-stimulating hormone (FSH) concentrations in jugular plasma in 50% of treated mares whereas no control mares had surges in FSH (P less than .05). The effect of treatment on luteinizing hormone (LH) concentrations was much less dramatic and only three treated mares appeared to have positive responses. Sponge-treated mares exhibited positive responses in FSH concentrations 11 times out of 32 mare-days and control mares zero out of 28 (P less than .05). The magnitude of the FSH response decreased rapidly with successive responses. Sponge insertion induced estrus in four of eight treated mares; no control mares exhibited estrus (P less than .05). Sponge insertion also increased ovarian size and the incidence of large follicles. When all mares were fed altrenogest for 14 d beginning February 1, there was no beneficial effect of sponge treatment on number of mares exhibiting estrus or on pregnancy rate. These data confirm earlier speculations that sponge treatment causes surges in gonadotropins and increased ovarian size in approximately 50% of anestrous mares. However, sponge treatment does not appear to provide a practical means of preparing mares for progestogen synchronization during the nonbreeding season.  相似文献   

16.
Our hypothesis was that estrus synchronization in beef cattle using melengestrol acetate (MGA) and an injection of progesterone (P4) and 17beta-estradiol (E2) to regress dominant ovarian follicles would improve pregnancy rate (number conceived/number in group) to AI compared with feeding only MGA or injecting PGF2alpha. During 2 yr, peripubertal heifers (n = 52) and cows (n = 327) received either 1) MGA for 18 d (d 0 = 1st d of MGA) plus an injection of P4 and E2 in sesame oil (vehicle) on d 11 to regress persistent ovarian follicles (MGA+P4), 2) MGA for 18 d plus vehicle on d 11 (MGA), or 3) two injections of PGF2alpha 10 d apart (d 7 and 17, PG). Concentration of P4 was assessed in blood samples obtained on d 0, 7, and 17 to indicate estrual status (anestrual or estrual) during treatment to induce estrus synchrony. Observations for detection of estrus occurred every 6 h for 180 h following treatment cessation. Females showing estrus were inseminated 6 to 12 h after estrus detection. Conception to AI was determined by ultrasonography 35 to 40 d later. Conception rate was greater (P < .05) in females in the PG than in those in the MGA group but did not differ from conception rate of females in the MGA+P4 group. Among anestrual females, estrus synchrony rates were greatest (P < .10) among females treated with MGA+P4. Among females that were estrual before treatment cessation, estrus synchrony rates were greater (P < .10) among females treated with MGA+P4 or PG than among those given MGA. Pregnancy rates were greater (P < .05) among females that were anestrual before treatment cessation and treated with MGA or MGA+P4 than among those treated with PG. Estrus synchronization using MGA+P4 and E2 differentially improves estrus synchronization and pregnancy rates among anestrual and estrual beef cattle while maintaining conception rates similar to those of PGF2alpha-treated females.  相似文献   

17.
Expanded use of artificial insemination in the beef cattle industry depends on successful application of treatments designed to synchronize estrus. Regulation of estrous cycles is associated with control of the corpus luteum (CL), whose life span and secretory activity are subject to trophic and lytic mechanisms. The advantages of melengestrol acetate (MGA) in estrous synchronization incorporate ease of administration, lower cost relative to other estrous synchronization products, and potential for use to induce estrus in prepubertal heifers. Treatments first designed to synchronize estrous cycles of normally cycling heifers by feeding MGA were imposed daily for 14 to 18 d at levels of .5 to 1 mg. The minimal daily effective dose required to inhibit ovulation was .42 mg. Longer feeding periods of MGA were associated with low fertility at the first synchronized estrus, but at the second estrus, conception was normal. Low fertility at the synchronized estrus resulted in development of alternative treatment practices, which combined feeding of MGA with injections or implants of estradiol-17 beta, estradiol cypionate, luteinizing hormone, human chorionic gonadotropin, pregnant mare serum gonadotropin, or oxytocin. Estrus was synchronized after MGA and estradiol-17 beta or estradiol cypionate treatments, but fertility was low. Short-term feeding of MGA (5 to 7 d) combined with prostaglandin F2 alpha or its analogs (PGF) on the last day of MGA reduced fertility at the synchronized estrus. The reduced conception at first service occurred in animals that began treatment after d 12 of the estrous cycle. However, feeding MGA for 14 d and then injecting PGF 17 d later avoided problems with reduced conception. Fertility of animals after this treatment was similar to that of contemporaries synchronized with Syncro-Mate-B. However, the length of the treatment period creates a need for increased management and may extend management beyond practical limits. Further research is warranted to address problems associated with reduced fertility after short-term treatment with MGA.  相似文献   

18.
Two experiments were performed to evaluate the efficacy of a progestin-based estrus synchronization program that incorporated the use of estradiol at the initiation of progestin treatment and at 48 h after progestin withdrawal (Exp. 2). In Exp. 1, cyclic, lactating dairy cows (n = 112) were assigned to receive either 1 (1mg) or 2 (2mg) mg of estradiol benzoate via an i.m. injection on d -9 (d 0 = initiation of the breeding season). All cows received an intravaginal progesterone-releasing insert (IPI; CIDR-B) on d -9. On d -2, the IPI was withdrawn and all cows were administered 500 microg of cloprostenol sodium. Beginning on d 0, cows were bred by AI upon detection of estrus. Estrus was observed in similar proportions of cows in each treatment during the first 6 d of AI (90% across treatments), but the interval to estrus was shorter (P < .05) in 1mg (1.26 +/- .18 d) than in 2mg (1.77 +/- .18 d). Conception and pregnancy rates did not vary among treatments; however, cows in estrus on d 0 tended to be less fertile (P = .11) than those in estrus on d 1. In Exp. 2, 408 cyclic cows from three herds were assigned to receive either no synchrony treatment (Control, n = 214) or the treatments described in Exp. 1 (1mg, n = 100; 2mg, n = 94). Anestrous cows from all herds received an IPI from d -9 to -2 (n = 143; Anestrus). All cows in the 1mg, 2mg, and Anestrus groups, with the exception of those detected in estrus between d -1 and 0, also received 1 mg of estradiol benzoate on d 0. Greater than 90% of cows that received an IPI were in estrus between d -1 and 3, and 92.1% of cows in the Control group were in estrus by d 21. Conception rate to first service in 2mg (61.7%) was similar to Control (57.0%), tended to be higher (P = .06) than 1mg (49.0%), and was greater (P < .05) than Anestrus (39.9%). The mean day of conception was earlier (P < .05) in the 2mg (d 13.1 +/- 2.0) than the Control (d 23.2 +/- 1.6) and Anestrus (d 22.4 +/- 1.9) groups. Conception occurred earlier in 1mg (d 17.4 +/- 2.1) than in Control. The proportion of cows that were pregnant at the end of the breeding season tended (P = .09) to be greater in the 2mg and Anestrus groups. This regimen of estrus synchronization improved reproductive competence in cyclic cows and resulted in similar reproductive performance in anestrous cows and untreated cyclic cows inseminated at a spontaneous estrus.  相似文献   

19.
Seventy-eight Simmental-Angus-Hereford crossbred yearling heifers, in 1983, and 99 similar heifers, in 1984, were used to compare two estrous synchrony regimens. One treatment group (SMB) was synchronized using the commercially available Syncro-Mate-B procedure, which involved placing a norgestomet implant in the ear for 9 d and giving an injection of norgestomet and estradiol valerate at the time of implantation. A second group (PR + PG) was given a norgestomet implant (PR) for 7 d and a 5-mg injection of alfaprostol (PG) at implant removal. Percentage of heifers cycling during the synchronization period and percent conceiving in 5 d or 30 d were not different (P greater than .10) due to treatment. The interval from implant removal to onset of behavioral estrus was shorter (P less than .01) for the heifers treated with SMB than for the heifers treated with PR + PG (42.8 vs 58.0 h). The group treated with SMB had a more uniform synchrony of estrus than the group treated with PR + PG. The effect of day of the estrous cycle at implantation on hours to estrus after implant removal was determined by a regression analysis, which showed a linear response for the SMB group with a slope of .78 (P = .09); the PR + PG group regression was cubic (P less than .01); this also indicated a more uniform response by the SMB group. These results indicate that the combination of norgestomet and alfaprostol produced more variation in interval from treatment to estrus than the Syncro-Mate-B procedure.(ABSTRACT TRUNCATED AT 250 WORDS)  相似文献   

20.
The effect of GnRH pretreatment on estrus detection rate, precision of estrus, and reproductive performance of postpartum beef cows synchronized to estrus using GnRH and PGF2alpha was evaluated. In Exp. 1, Angus cows (n = 87) were randomly assigned by parity, postpartum interval, and body condition score (BCS) to receive either 1) GnRH on d -7 and PGF2alpha on d 0 (GP) or 2) the GP treatment and an additional injection of GnRH on d -16 (GGP). Estrus detection and AI were conducted twice daily from d -3 to d 3. At 72 h after PGF2alpha, all animals not previously detected in estrus were bred by AI and received a concurrent injection of GnRH (TAI). Synchronized pregnancy rates were numerically increased (P = 0.15) in cows treated with GGP (55%) compared with those on the GP treatment (44%). In Exp. 2, 1,276 spring-calving, suckled beef cows in nine herds were randomized to treatments as described for Exp. 1, except that the initial GnRH injection for the GGP treatment was administered on d -14. Herd affected all indicators of reproductive performance (P < 0.05). The percentage of animals detected in estrus prematurely (d -3 to d 0; 7%) was not affected by treatment. Estrus response rate was influenced by postpartum interval (< 60 vs > or = 60; 61 vs 73%; P < 0.01) and a three-way interaction of parity, BCS, and treatment (P < 0.01). Within animals with a BCS > or = 5.5, the GGP treatment tended to increase the detection of estrus in primiparous cows (GP vs GGP; 76 vs 91%; P = 0.11) and decrease detection in multiparous cows (GP vs GGP; 78 vs 72%; P < 0.10). However, because conception rate to TAI in animals with a BCS > or = 5.5 was greater (P < 0.05) in the GGP than in the GP group (28 vs 8%, respectively), this interaction was interpreted to represent a shift in interval to estrus induced by the GGP treatment, rather than a reduction in the synchronization of ovarian function. Conception rates of animals inseminated to an observed estrus did not differ among treatments (P = 0.15). Synchronized pregnancy rate tended (P = 0.06) to be greater in GGP- (53%) than in GP-treated animals (47%). In conclusion, pretreatment with GnRH tended to increase pregnancy rates during a 6-d synchronization period, primarily through enhanced conception rates of cows bred by TAI. In contrast to our hypothesis, GnRH pretreatment did not increase the percentage of animals detected in estrus or the precision of estrus expression.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号